Biomarker ID | 497 |
PMID | 19894759 |
Year | 2009 |
Biomarker | e-FABP5 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated in Localised PCA |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:-PPAR signaling pathway, Interleukin-1 regulation of extracellular matrix |
Experiment | Localized PCa and BPH |
Type of Biomarker | Diagnostic |
Cohort | Serum samples were obtained from 70 additional patients at the initial diagnosis, including 20 cases of localized PCa, 20 cases of LNM PCa and 30 cases of BPH |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.01 |
Method Used | ELISA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on Independent Patient Dataset |
Technical Name | FABP5 |